1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,340 | 1,440 | 17:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America | 311 | Business Wire | Currently being established in Brazil, Probantes is wholly owned by Aliko Scientific and based in Anápolis, Goiás, a major pharmaceutical and life sciences hub.
Probantes will serve... ► Artikel lesen | |
| 07.09. | Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World's Largest Molecular Diagnostics Exhibition | 317 | Business Wire | Strong first joint initiative at ADLM (Association for Diagnostics Laboratory Medicine) 2026, providing direct access to major international diagnostics players Significant interest generated... ► Artikel lesen | |
| 24.08. | Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum | 611 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, today provides additional financial... ► Artikel lesen | |
| 05.08. | Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network | 754 | Business Wire | €1.92 million in Romania and €2.05 million in Saudi Arabia in five-year minimum contractual purchase commitments Agreements covering Aliko Scientific's liquid-based cytology, FISH, microscopy... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 05.08. | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 166 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 30.07. | Aliko Scientific Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments | 726 | Business Wire | Total revenue up 52.6% to €1.64 million (vs. €1.08 million in 2024), driven by Hospitex' full-year contribution and the progressive rollout of Aliko Scientific's offering
EBITDA improved... ► Artikel lesen | |
| 23.07. | Aliko Scientific Tochter unterzeichnet Vereinbarung für Krebs-Screening in Usbekistan | - | Investing.com Deutsch | ||
| 23.07. | Aliko Scientific unit signs Uzbekistan cancer screening deal | 2 | Investing.com | ||
| 23.07. | Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | 361 | Business Wire | Confirmation of the growing international interest in Urine24 and significant recognition of Aliko Scientific's expertise in large-scale oncological diagnostic solutions Immediate launch... ► Artikel lesen | |
| 15.06. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 165 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 0,5... ► Artikel lesen | |
| 25.05. | Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden | 1 | Investing.com Deutsch | ||
| 25.05. | Aliko Scientific signs Brazil JV to manufacture FISH probes | 1 | Investing.com | ||
| 25.05. | Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture | 528 | Business Wire | Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and... ► Artikel lesen | |
| 19.05. | Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital | 403 | Business Wire | Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over... ► Artikel lesen | |
| 11.05. | Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona | 496 | Business Wire | Regulatory News:
Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics... ► Artikel lesen | |
| 10.03. | Aliko Scientific: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market | 492 | Business Wire | Regulatory News:
Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization... ► Artikel lesen | |
| 24.02. | Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform | 485 | Business Wire | Regulatory News:
Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition... ► Artikel lesen | |
| 18.02. | Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan | 542 | Business Wire | Regulatory News:
Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 19.12.25 | Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali | 543 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.25 | Ikonisys SA: Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born | 433 | Business Wire | Regulatory News:
Hospitex international, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,070 | -2,40 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| AETHLON MEDICAL | 7,380 | +416,08 % | Morning Market Movers: Aethlon Medical, CID HoldCo, Longeveron, Delixy See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS | 45,900 | -0,52 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,530 | +9,41 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| SIEMENS HEALTHINEERS | 38,620 | +0,68 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| BETA BIONICS | 21,620 | -2,52 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,39 | +0,73 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 102,46 | +5,11 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 29,360 | -3,10 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,150 | -0,77 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| ESSILORLUXOTTICA | 141,55 | -2,68 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| LIFESTANCE HEALTH GROUP | 13,065 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| HEARTFLOW | 49,165 | +1,73 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| DRAEGERWERK | 114,80 | +1,06 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| GERRESHEIMER | 27,520 | -0,51 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
11.09.2026 / 20:31... ► Artikel lesen |
Das Unternehmen IKONISYS SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,380 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS SA finden Sie auf Wallstreet Online.